Raisa Lomanto Silva, MD (@RaisaLomanto) header
Raisa Lomanto Silva, MD (@RaisaLomanto) profile picture

MGH Rheumatology Fellow @MGHrheumatology | UPMC Internal Medicine @PittDeptofMed | 🇧🇷| #HealthEquity

Pittsburgh, PA
Joined April 2015
Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)Photo by Raisa Lomanto Silva, MD (@RaisaLomanto)
Copayment >= $10 is associated with worse adherence to HCQ, AZA, and MMF in individuals with incident SLE! Very grateful for all the support I got and to ACR for giving me the opportunity to share our work in a Plenary session today! #ACR22 acrabstracts.org/abstract/me… – at Philadelphia, PA
7
6
1
55
Raisa Lomanto Silva, MD retweeted
🔥 Happy to share our manuscript @LancetRH_Americ WHtR was superior to BMI in predicting atherosclerosis Thiago Mendes @generosoMD @brunohalpern Carolina Janovsky, @carlosmanuelro @rauldsf_santos Isabela Bensenor @PauloLotufo @MBittencourtMD sciencedirect.com/science/ar…
1
2
7
1,192
Raisa Lomanto Silva, MD retweeted
🔖2025 Annual Alan Lerner Research Symposium @BrighamWomens ❤️‍🔥GlycA Predicts CV Events - VITAL TRIAL Insights Many thanks to my mentor @SamiaMoraMD and her incredible multidisciplinary team!
2
2
24
1,049
New EULAR/ACR classification criteria for Antisynthetase Syndrome ✅ Anti-ARS antibodies & ILD are top drivers 🧪 ANA, SSA, MSA testing crucial to apply/exclude criteria 🧠 Score ≥5.5 + anti-ARS = definite ASyS ⏩ most weighted items = anti-ARS , ILD, myositis #EULAR2025
1
62
120
6,058
Raisa Lomanto Silva, MD retweeted
Idiopathic inflammatory #myositis -#ILD treatment #EULAR2025
66
139
9,164
Raisa Lomanto Silva, MD retweeted
RIVAWAR Trial: Rivaroxaban Is Comparable to Warfarin for Post-MI Left Ventricular Thrombus Written by @adam_dr_! Summary, analysis and more #ACC25 coverage below! cardiologynownews.org/rivawa… @CMichaelGibson @ceciliabahit
5
11
1,861
Raisa Lomanto Silva, MD retweeted
Dr. Belen Arevalo & Dr. Zandra Walton present difficult #vasculitis cases from @MassGenBrigham #MGB2025VasculitisPMR #meded #GCA #GPA #cranialnervepalsies #opticneuritis – at Cambridge, MA
2
2
376
Raisa Lomanto Silva, MD retweeted
🆕 PJP Prophylaxis in #Rheumatology 🫁 Created with / Review by @CCalabreseDO 🔹Discuss risk factors for PJP infection 🔹Risk Stratify: CD4 count <200 or ALC <500 = ⇡Risk 🔹Review Treatment options and when to stop PPx? #RheumX #RheumTwitter #PulmTwitter #PJP
12
114
3
285
33,766
Raisa Lomanto Silva, MD retweeted
We have a great program lined up for this upcoming 2-hr webinar on #IBM dedicated to patients and providers, and it is cost free. Hope to see you all ! @MyositisSupport @CureIBM @TheMyositisAssc @aanem @aan
1
2
1
7
944
Start spotlight, SO proud 🥹 ⭐️
Very honored to have been selected as the member spotlight for @carrainc this month. This organization played a very important role in my training, and gave me great opportunities. I’m very glad to be an active part of it 😊 carragroup.org/blog/carra-me…
1
3
468
Raisa Lomanto Silva, MD retweeted
#AHA24 Prior studies: ⬆️vol. physical act (PA) linked ⬆️CAC in suggesting early atherosclerosis Our findings: ⬆️Vol. PA was 🚫 linked w/ ⬆️CAC in asympt w/o CVD ELSA-Brasil cohort Longitudinal athlete-level data is lacking Thx my mentor @MBittencourtMD and all ELSA-Brasil
3
6
27
1,352
Abstract 333 showed that in a cohort of patients with IIM-ILD increased age, PH, FVC decline at 1 yr, SOB at 2 years were predictors for mortality and lung transplant ! #ACR24 @RheumNow
2
4
27
2,292
Flashback circa 2015, best slide at the Great Debate on MCTD! #ACR2024
1
1
9
827
Raisa Lomanto Silva, MD retweeted
Superstar fellow Raisa Silva and incoming resident Manuel Carpio Tumba presenting #ACR24 poster on geographic, racial and ethnic representation in myositis clinical trials 🌟 @RaisaLomanto
6
37
1,955
In our syst. review.. - Race fully reported in 57.9% RCTs - 42% of RCTs had >20% non-White participants; 21% if excluding RCTs conduted exclusively in Japan - 68.4% RCTs used sex/gender terms per SAGER guidelines Working with the best ⭐️ @DidemSayginMD @SattuiSEMD @manuctumba
3
4
1
23
5,311
Fangirling these two rockstars! A joy to work with @shirikeret and @Irada0720 on ILD transplant-free survival predictors 🫁 @docrota
1
11
442
Raisa Lomanto Silva, MD retweeted
I can’t begin to describe how much it filled me with joy to see Dr. Eloisa Bonfa receive the #ACR master designation. Seeing a great clinician and investigator from Brazil show up in that stage; and even more being from my home institution of USP, words can’t describe. 🇧🇷 1/
1
2
16
878
Raisa Lomanto Silva, MD retweeted
📣 FOMO on #AHA24? Catch all the🫀🗞️highlights from the CardioNerds Conference Scholars by following @CardioNerds & #AHA24👩‍⚕️👨‍⚕️ @AmitGoyalMD @Dr_DanMD @NaimaMaqsood9 @Gurleen_Kaur96 @Ronaldo_CFF @catweneboah @AtefehGho @MaryamBMD @Shikha_Cardio @DanAmponsahMD
7
7
22
18,718